These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26372146)

  • 1. Cost-effectiveness analysis of neurocognitive-sparing treatments for brain metastases.
    Savitz ST; Chen RC; Sher DJ
    Cancer; 2015 Dec; 121(23):4231-9. PubMed ID: 26372146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
    Lester-Coll NH; Dosoretz AP; Magnuson WJ; Laurans MS; Chiang VL; Yu JB
    J Neurosurg; 2016 Dec; 125(Suppl 1):18-25. PubMed ID: 27903191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness Analysis of Stereotactic Radiosurgery Alone Versus Stereotactic Radiosurgery with Upfront Whole Brain Radiation Therapy for Brain Metastases.
    Kim H; Rajagopalan MS; Beriwal S; Smith KJ
    Clin Oncol (R Coll Radiol); 2017 Oct; 29(10):e157-e164. PubMed ID: 28552517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
    Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
    Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision analysis of stereotactic radiation surgery versus stereotactic radiation surgery and whole-brain radiation therapy for 1 to 3 brain metastases.
    Lester-Coll NH; Dosoretz AP; Yu JB
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):563-8. PubMed ID: 24751412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness of Subsequent Whole-Brain Radiotherapy or Hippocampal-Avoidant Whole-Brain Radiotherapy Versus Stereotactic Radiosurgery or Surgery Alone for Treatment of Melanoma Brain Metastases.
    Tran AD; Fogarty G; Nowak AK; Diaby V; Hong A; Watts C; Morton RL
    Appl Health Econ Health Policy; 2020 Oct; 18(5):679-687. PubMed ID: 32157631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiosurgery plus whole-brain radiotherapy for treatment of multiple metastases from non-small cell lung cancer.
    Minniti G; Salvati M; Muni R; Lanzetta G; Osti MF; Clarke E; Costa A; Bozzao A; Trasimeni G; Enrici RM
    Anticancer Res; 2010 Jul; 30(7):3055-61. PubMed ID: 20683055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
    Karlovits BJ; Quigley MR; Karlovits SM; Miller L; Johnson M; Gayou O; Fuhrer R
    Neurosurg Focus; 2009 Dec; 27(6):E7. PubMed ID: 19951060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases.
    Tsao M; Xu W; Sahgal A
    Cancer; 2012 May; 118(9):2486-93. PubMed ID: 21887683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of a randomized study comparing radiosurgery with radiosurgery and whole brain radiation therapy in patients with 1 to 3 brain metastases.
    Lal LS; Byfield SD; Chang EL; Franzini L; Miller LA; Arbuckle R; Reasonda L; Feng C; Adamus A; Swint JM
    Am J Clin Oncol; 2012 Feb; 35(1):45-50. PubMed ID: 21293245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial clinical experience with frameless radiosurgery for patients with intracranial metastases.
    Kamath R; Ryken TC; Meeks SL; Pennington EC; Ritchie J; Buatti JM
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1467-72. PubMed ID: 15817352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the cost-effectiveness of two brain metastasis treatment modalities from a payer's perspective: stereotactic radiosurgery versus surgical resection.
    Vuong DA; Rades D; van Eck AT; Horstmann GA; Busse R
    Clin Neurol Neurosurg; 2013 Mar; 115(3):276-84. PubMed ID: 22705458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
    Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised prospective phase II trial in multiple brain metastases comparing outcomes between hippocampal avoidance whole brain radiotherapy with or without simultaneous integrated boost: HA-SIB-WBRT study protocol.
    Chia BSH; Leong JY; Ong ALK; Lim C; Poon SH; Chua MLK; Chua KLM; Kusumawidjaja G; Chua ET; Wong FY; Lee TS
    BMC Cancer; 2020 Oct; 20(1):1045. PubMed ID: 33126867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic radiosurgery for patients with "radioresistant" brain metastases.
    Brown PD; Brown CA; Pollock BE; Gorman DA; Foote RL
    Neurosurgery; 2002 Sep; 51(3):656-65; discussion 665-7. PubMed ID: 12188943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of surgical resection and cesium-131 intraoperative brachytherapy versus surgical resection and stereotactic radiosurgery in the treatment of metastatic brain tumors.
    Wernicke AG; Yondorf MZ; Parashar B; Nori D; Clifford Chao KS; Boockvar JA; Pannullo S; Stieg P; Schwartz TH
    J Neurooncol; 2016 Mar; 127(1):145-53. PubMed ID: 26725100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of stereotactic radiosurgery for multiple brain metastases in stable systemic disease: a review of the literature.
    Khalsa SS; Chinn M; Krucoff M; Sherman JH
    Acta Neurochir (Wien); 2013 Jul; 155(7):1321-7; discussion 1327-8. PubMed ID: 23636335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of five or more brain metastases with stereotactic radiosurgery.
    Hunter GK; Suh JH; Reuther AM; Vogelbaum MA; Barnett GH; Angelov L; Weil RJ; Neyman G; Chao ST
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1394-8. PubMed ID: 22209150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.